Susquehanna International Group’s Pardes Biosciences, Inc. Common Stock PRDS Stock Holding History

Susquehanna International Group’s Portfolio PRDS Stock Details PRDS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-15,846	Closed	-$20.9K	–	13572
2023 Q1	$20.9K	Buy	+15,846	New	+$25.9K	﹤0.01%	12037
2022 Q4	–	Sell	-10,535	Closed	-$19K	–	14194
2022 Q3	$19K	Buy	+10,535	New	+$31.4K	﹤0.01%	12625
2021 Q4	–	Sell	-44,247	Closed	-$440K	–	14192
2021 Q3	$440K	Hold	44,247	–	–	﹤0.01%	9717
2021 Q2	$442K	Hold	44,247	–	–	﹤0.01%	9891
2021 Q1	$441K	Buy	+44,247	New	+$458K	﹤0.01%	9772

Other funds holding PRDS

FCMV

Foresite Capital Management V Larkspur, California $271M AUM 309.87% 1-Year Est. Return

VK Services Menlo Park, California $543K AUM 174.84% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

ACA

Arena Capital Advisors Los Angeles, California $208M AUM 11.42% 1-Year Est. Return

WSL

Western Standard LLC Los Angeles, California $190M AUM 40.88% 1-Year Est. Return

Susquehanna International Group's PRDS Position: Q2 2023 in Review

Susquehanna International Group sold out of Pardes Biosciences, Inc. Common Stock (PRDS) in Q2 2023, closing a stake of 15,846 shares — an estimated $20.9K sold.

Susquehanna International Group first reported a position in PRDS in Q1 2021 and held it in 5 quarters. The position peaked at $442K in Q2 2021. 59 funds tracked by Wall St. Rank hold PRDS as of Q2 2023.

Susquehanna International Group reported no remaining Pardes Biosciences, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Susquehanna International Group sold 15,846 Pardes Biosciences, Inc. Common Stock shares in Q2 2023, an estimated $20.9K.
Susquehanna International Group first reported a position in Pardes Biosciences, Inc. Common Stock in Q1 2021 and held it in 5 quarters.
Susquehanna International Group's Pardes Biosciences, Inc. Common Stock position peaked at $442K in Q2 2021.
59 funds tracked by Wall St. Rank held Pardes Biosciences, Inc. Common Stock as of Q2 2023.

Based on Susquehanna International Group's 13F filing for Q2 2023, filed 11 Aug 2023.